|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Revenues from sale of products | |||||
| Other revenues | |||||
| Total net revenues | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Research and development expenses | |||||
| Other income and expenses, net | |||||
| Impairment, restructuring charges and other related phase-out costs | |||||
| Operating income | |||||
| Interest income, net | |||||
| Other components of pension benefit costs | |||||
| Gain (loss) on financial instruments, net | |||||
| Income (loss) before income tax benefit (expense) | |||||
| Income tax expense | |||||
| Net income | |||||
| Net income attributable to noncontrolling interest | |||||
| Net income attributable to parent company stockholders | |||||
| Earnings per share (basic) attributable to parent company stockholders (in usd per share) | |||||
| Earnings per share (diluted) attributable to parent company stockholders (in usd per share) |
Loading...